SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " dup " 968 found 🔀 AI-powered Shuffle
Mapping the Global Health Landscape: Analysis of Fourteen International Organizations
The global health architecture includes a number of diverse international organizations with different mandates, governance models, financing structures, and operational approaches. This KFF resource looks across a range of variables to provide a descriptive mapping of 14 key global health and related international institutions. It is intended to inform discussions about synergies and coordination, duplication, comparative advantage, shared challenges, and architectural reform.
Roundup: Using AI to better integrate virtual modalities into care delivery
Artificial intelligence enhancements in telehealth aim to bolster care continuity while virtual nursing extends bedside care. Also, Zocdoc integrates with Google Gemini to book appointments while Sword Health is set to acquire Headspace's parent company.
National politics roundup
We’re digging into all the top headlines with local commentators on either side of the .
Roundup: Energy employment / Small business confidence / Maritime woes
Jobs in transition: Energy sector employment fell about 1% nationwide and in Louisiana from 2024 to 2025, with Louisiana losing 1,131 jobs to reach roughly 160,000 workers. The decline was driven largely by automation, policy changes affecting renewable energy, and shifting economics, while traditional energy industries such as coal and nuclear saw job growth. Despite […]
AZ's R&D chief Barr touts internal 'science success story' after IL-33 antibody's stellar showing in COPD
With a detailed data drop that AstraZeneca’s R&D chief described as an internal “science success story,” the British Big Pharma has secured an FDA priority review for what it believes could become a flagship biologic in chronic obstructive pulmonary disease (COPD). In detailed results from the late-stage Oberon and Titania trials—first teased in March and detailed in full at the European Respiratory Society Congress in Barcelona this week—the drugmaker laid out the extent of its IL-33 inhibitor’s potential to reduce moderate and severe exacerbations in a wide range of COPD patients still struggling with those “lung attacks,” as AstraZeneca’s Sharon Barr, Ph.D., called them, despite using standard-care inhaled therapy. In the headline results, a 300 mg dose of tozorakimab given once every four weeks curbed those moderate and severe exacerbations in the studies’ primary population of former smokers by 29% in the Oberon study and 34% in Titania. In the overall population of both current and former smokers, these reductions were 30% and 29%, respectively, versus placebo and inhaled standard of care. The benefits also extended to clinically meaningful exacerbation reductions in all prespecified patient subgroups and specifically turned up promising signals in patients across a range of blood eosinophil counts, with Barr telling Fierce that “it’s the details that make this even more exciting than the high-level results that we’ve already shared.” In fact, during AZ’s tozorakimab poster presentation at the ERS 2026 Congress this past weekend, attendees were so enamored by the data that event organizers had to encourage people to clear the room and look at the other presentations on offer, Barr said in an interview. “I think it really speaks to the fact that there is a lot of buzz around these data because the entire respiratory community has been so desperate for new therapies for these patients,” she explained. The respiratory disease continues to represent a “staggering unmet medical need,” Barr said, highlighting the COPD exacerbations that the Oberon and Titania studies homed in on, which she added carry a greater mortality risk than a heart attack. “When a patient has a severe exacerbation, only about half of them are still alive within three and a half years,” she pointed out. As for tozorakimab specifically, Barr christened the molecule “an AstraZeneca science success story,” harkening several years back to the point at which researchers began to explore IL-33 as a driver of respiratory disease, and COPD in particular. At the same time, “there was still so much that wasn’t understood,” she admitted, highlighting the insight that IL-33 signals through both ST2 and EGFR through the RAGE pathway, a discovery Barr attributed to AstraZeneca's own scientists. Understanding the need to tackle both pathways in COPD—and aware of competitor candidates in the hopper, including one that bound ST2—the company ultimately had to make some “courageous decisions,” Barr said. These included taking a prior COPD molecule offline and going back to the drawing board to reinvent its potential IL-33 label “to make sure that we had a molecule that could block signaling through both arms of the pathway, through both the reduced form and the oxidized form, knowing that we wouldn’t be first, but striving to be best.” “When we put [tozorakimab] into the clinic, we firmly believed that we had a differentiated molecule, and we saw the other molecules blocking just ST2 or partially blocking IL-33, unable to deliver two positive pivotal studies in COPD,” Barr explained. “We kept marching forward because we believed our molecule was differentiated, and now I think we have the clinical validation that supports that.” Ultimately, AstraZeneca finds itself on much better footing these days when it comes to potential biologic rivals to tozorakimab in COPD. Sanofi and Regeneron’s Dupixent, for instance, is approved to treat COPD exacerbations in patients with high eosinophil counts, but not low ones. Meanwhile, the future has become cloudier for other next-gen IL-33 candidates from Sanofi and Regeneron, as well as Roche, which have suffered trial flops in recent years. One other potential ingredient for AstraZeneca’s success in its duo of studies was that the company was “ambitious in the trial design, willing to look at an all-comers population,” Barr said, “and willing to enroll the most severe patients.” Prior studies for would-be biologics rivals in COPD “avoided enrolling” those patients, she pointed out. She also highlighted the Big Pharma’s painstaking design of exacerbations in its trial, which “gave us a very rigorous readout,” and pointed to “the extra effort and investment” the company put in to understand the effect of mucus plugs in patients. Barr described mucus production as a “key feature in disease diversity,” noting that mucus plugs—obstructing clumps of mucus that block patients’ airways—are associated with worse outcomes in COPD. In its data announcement, AstraZeneca noted that an integrated analysis of Oberon and Titania found tozorakimab “demonstrated a reduction in patients’ mucus plug score,” with the pharma claiming its biologic is the first to deliver such results in a broad COPD population. “So being able to reduce those mucus plugs, we expect, is an important part of driving benefit for patients who are living with COPD,” Barr said. Again touching on the breadth of the study populations, Barr added that tozorakimab “worked across all eosinophil levels in both current and former smokers across all levels of lung function,” which she suggested “really simplifies decision-making for clinicians, and it allows them to offer therapy to the broadest possible patient population.” In the highest patient eosinophil count group, tozorakimab helped chart a 43% reduction in exacerbation risk, which Barr stressed were “unprecedented data.” In the mid-level group, AZ’s drug delivered a 23% reduction and, in the lowest group, a 34% reduction in eosinophils, which Barr said suggests efficacy “in all patient subgroups.” As for AZ’s recent guidance upgrade on the medicine’s sales opportunity, the lift from a $3 billion to $5 billion range to $5 billion plus was informed by multiple factors, Barr said, including the fact that “in 2024, there were multiple competitors, and there aren’t anymore.” Additionally, “we know that this is a massive unmet medical need, and this is a really incredible set of data that we think will be very convincing to the clinical community,” Barr said. Looking ahead to a potential evolution of the COPD treatment landscape, Barr noted that most patients start treatment in the community with an option like a triple therapy, and for them, having an option like AstraZeneca’s inhaler Breztri will remain a “really important part” of that journey. But of the patients uncontrolled on triple therapy, which Barr described as “about half of them today,” just a “small fraction” are currently eligible for biologic therapy, which she emphasized AstraZeneca is working to change. Understanding that COPD is not a “one-size-fits-all” disease, AstraZeneca is also looking at its antibody drug Tezspire for patients with T2-driven disease, and the company continues to think about new mechanisms for tackling COPD through both systemic and inhaled drugs, Barr said.
UEFA Champions League: Tuesday, Sept. 8 Preview and Predictions
The 2026-27 Champions League is finally here. After months of domestic buildup and qualifying drama, the league phase kicks off tonight with a full slate of intriguing openers. New managers, rebuilt squads, and familiar rivalries all collide as Europe’s elite return to the biggest stage. Here are the predictions for all six matches on opening […] The post UEFA Champions League: Tuesday, Sept. 8 Preview and Predictions appeared first on HEAVY.
‘Pawn Stars’ star Rick Harrison gets major health update after emergency heart surgery
It comes just days after he was rushed into surgery.
‘Pawn Stars’ star Rick Harrison gets major health update after emergency heart surgery
It comes just days after he was rushed into surgery.
Seminole Roundup: Soccer Draws While Volleyball Hosts SEC Foe
Wrianna Hudson nets a late goal as soccer battles Rice, while volleyball preps for an Auburn clash and golf sensations Shawn Coultoff and Sophia Fullbrook ignite strong starts.
Riverhead Town Board roundup: Town votes in favor of $1.95M offer to acquire the LI Science Center on East Main Street
The Riverhead Town Board voted to issue a $1.95 million appraisal offer to the Long Island Science Center for its East Main Street building in the downtown.
Roundup: Here's What The Reviews Are Saying About Hot Wheels: Infinite Rush
Launching this Thursday on Xbox Series X and Xbox Series S
Onimusha Sells 1 million in a Day as Capcom Vows to 'Re-activate' More Old Series
After a 20-year hiatus, the historical action game is yet another Capcom hit
What's happening in Pensacola? See what's new, what's next, in food, business, traffic
Check out our roundup of the new businesses, major ribbon cuttings, and upcoming projects that could impact your family, neighborhood and commute.
The science behind the perfect pole vault | News | Budapest 26
Mondo Duplantis can often make the pole vault look easy as he clears world-record heights. But as Athanassios Bissas explains, there is so much more complexity to it. The Greek professor unpicks the science behind the perfect pole vault.
From the Valley to FBS: Lowry leads Week 1 roundup
There is plenty of Valley talent spread across Division I FBS football. Here's a look at how local players performed in Week 1.
Bonus Features – September 6, 2026 – 59% of clinicians say TikTok is the top source of misinformation about GLP-1s, AMA names leader for new Center for Digital Health and AI, plus 32 more stories
Welcome to the weekly edition of Healthcare IT Today Bonus Features. This article will be a weekly roundup of interesting stories, product announcements, new hi
Music in the Garden closes with the Carpinos
The month of concerts at Payson’s community college campus is now a recent memory, but the impact it will have on local students is long-lasting.
Fall vaccine recommendations released, more Health Headlines
A roundup of regional health news and medical updates affecting residents across Grand Junction and Mesa County.
The Invisible Aftermath: How COVID Changed Young Adult Mental Health and Addiction
Flagstaff Business News The Invisible Aftermath: How COVID Changed Young Adult Mental Health and Addiction
Business roundup: Three up-and-coming businesses reach Columbia
Marcos Pizza, The Fifth Season and The Plant Shop are now open in Columbia.
High school sports roundup for Sept. 3, 2026
Volleyball Everett defeated Mountlake Terrace 3-1 25-17, 22-25, 25-20, 25-22 Everett top individual stats: Ava Gonzalez: 17 kills and 14 digs Ava Urbanozo: 29 assists and 11 digs Marley Lockey: […]
First midterm ballots mailed, federal roundups of wild horses
Watch the full episode here.
The Political Recap: Will Virginia ban Flock cameras?
Here’s your weekly roundup of what happened in Virginia politics on The Political Recap.
Your Weekly Michigan Political Brief
Democratic U.S. Senate nominee Abdul El-Sayed has been endorsed by the American Federation of State, County and Municipal Employees (AFSCME) and the IAM Union’s Michigan Machinists Council. EMILYs List endorsed Michigan Senate Majority Leader Winnie Brinks for Michigan lieutenant governor. Former U.S. Senator Debbie Stabenow has endorsed Rebecca Amidon, Democratic candidate for Michigan’s open 32nd […]
Aubrey O’Day says modern pop star offered $50,000 to have sex with her
Danity Kane singer Aubrey O’Day alleges that a ‘huge star’ once offered her $50,000 to have sex with him, and says another proposed they have sex for $150,000: ‘Some of the gatekeepers played dirty.’
Cancer drug tames atherosclerosis inflammation and plaque in animal models
A new Yale study has identified a promising therapeutic avenue for atherosclerosis, a condition caused by inflammation and plaque buildup in arteries. Martin Schwartz, Ph.D., Robert W. Berliner Professor ...
Genome Duplication Is a Radical Evolutionary Gamble
By doubling their entire genome, organisms can evolve extremely rapidly — or they can lose it all. New studies reveal how to survive the high-risk, high-reward evolutionary event.
Alzheimer’s may leave a mark on the brain long before plaques appear
Brain changes associated with Alzheimer’s may begin at least seven years before amyloid plaques become detectable with current PET scans. Researchers uncovered the signal by tracking healthy older adults with repeated brain imaging over nearly 20 years. The discovery could help scientists identify Alzheimer’s earlier and suggests that important disease processes may start before visible plaque buildup.
MM 9.2: Maryland athletics holds fall sports media day
This is the Maryland Minute, a short story followed by a roundup of Terps-related news.
August Monthly Review: ChatGPT In Epic
Death, taxes, another frontier lab healthcare launch inspiring truly insane LinkedIn takes. As much as I want to stay away, I repeatedly am the crewman unplugging his ears whenever we pass these sirens. So it’s not the first and probably not the last time we dial up the typewriter rather than tie ourselves to the mast. The full blow-by-blow timeline: Health API Guy is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Subscribe The End of the Standalone PHR (Jan 8): ChatGPT Health arrives for consumers, at the time powered by b.well. I was bullish on the approach in that the best way for the PHR to finally solve distribution was to meet consumers were they already are (i.e. When Horizontal Meets Healthcare (Jan 9): OpenAI for Healthcare puts out the shingle for enterprises, with SharePoint ingestion standing in for the EHR integration the product actually needed. Another One: Anthropic’s Healthcare Debut (Jan 16): Claude's version, on HealthEx rails instead of b.well, with Agent Skills for FHIR development as the one true vertical-specific investment. ChatGPT for Clinicians: The Trap Sprung (Apr 24): OpenAI filled in the missing GTM middle with a free product for verified clinicians, effectively peeling the enterprise wrapper off ChatGPT for Healthcare and taking the PLG fight directly to OpenEvidence. OpenAI’s Second Attempt at Health (Jul 31): a relaunch of their patient specific app, now branded Health in ChatGPT, where the privacy partition came out, the connectors thinned, and b.well disappeared in favor of first-party FHIR work against a smaller network Beyond a Shingle So what was announced now? Today, we’re introducing a new electronic health record integration that brings authorized patient context from Epic into ChatGPT for Healthcare, along with the Healthcare Public Data plugin for direct, structured access to official healthcare datasets like PubMed, DailyMed, and CMS Coverage. Together, these capabilities bring ChatGPT closer to the systems and sources healthcare teams trust, while supporting the controls and compliance healthcare work requires. The core portfolio is unchanged from prior announcements we delineated and discussed (aside from the relaunch of patient-facing). Since trade publications still seem to be confusing them by using the wrong names: Enterprise sales motion: ChatGPT for Healthcare Protecting their core product / PLG: ChatGPT for Clinicians Consumer/patient-facing product: Health in ChatGPT So really, this is a feature release (specifically for ChatGPT for Healthcare when it comes to EHR integration). What’s cool about it, though, is that we are moving beyond just putting out a shingle. Everything in the January enterprise launch was horizontalizable: Horizontal tech companies thus generally start verticalization with their “putting out a shingle phase”. Telling the world you’re open for business as a horizontal tech company reliably attracts early inbound interest from buyers who are already trying to force-fit horizontal tools into domain-specific workflows and are eager for any signal that the vendor intends to support their use case more directly. Nothing was really vertical specific, which is exactly what you'd expect from the ultimate hypergrowth horizontal company dipping their toes into specific industries. But eventually you have to stop changing the sign on the door and start changing the product. Can you guess where the horizontal product was going to run out of road? This is the core dilemma writ large: verticalization requires differentiation, while scale economics of consumer and horizontal push toward unification. I’ve buried the lede so deep here it will be painful to some readers, but what should be shocking to no one is that my perspective is that EHR integration is the only path that meaningfully resolves this tension for ChatGPT for Healthcare. Integration with Microsoft Sharepoint is fine, but it is categorically insufficient for any product that hopes to influence clinical decision-making. SMART Money Well here we are, eight months later! Real vertical investment has begun, which surprised a few people. One friend in the industry messaged me: “Absolutely no way Epic gave ChatGPT API access.” Looking forensically at the announcements, the integration is notably read-only across appointment notes, laboratory results, medications, and specialist documentation. So while I’m not a betting man, I'd wager the house this is a SMART on FHIR launch: That sounds a lot like USCDI! The recommended path for the workflow they outline would be SMART on FHIR Their Health AI lead’s post is evocative of both standalone and EHR launch SMART, which another termed “ChartGPT” and “EHR Plugin” The implementation burden for SMART on FHIR is the lowest of the available integrative paths This is the team who literally did patient-facing SMART on FHIR with Epic last month Most importantly, if you’re a horizontal company, you generally still haven’t taken the full plunge and thus (overly) value reusability. SMART on FHIR is the logical compromise: healthcare-specific enough to matter, but standardized enough to reuse. Nobody Asked Judy Another friend asked “I thought they had to go to each health system, or did they go direct to Epic and now health systems opt in?” Given the trust paradigms in healthcare, this functionally cannot be Epic hoovering up all the data for OpenAI and shoving ChatGPT in their customers’ faces (or they would revolt). However, I do believe the aforementioned terrible coverage by TechCrunch and other outlets is probably responsible for that question, given the 325 million reference. When using FHIR as a business associate to an Epic customer, there is no EHR gatekeeping to speak of, as that isn’t how fhir.epic.com works: You register an app You pick your APIs You test against the sandbox APIs You list as “Ready for Production” Hospitals pick your app You test and go live with them Bluntly, nobody had to say yes or no in Verona (nor were they given the chance). Vendor Services (their next developer tier up that I doubt OpenAI is using quite yet in this initial release) certainly has contractual paperwork that some resent, but even there, the twin pressures of mounting antitrust and information blocking make outright gatekeeping increasingly fraught. My friend’s sentiment is, to me, representative of a broader industry neurosis, perhaps a sort of scar tissue of prior eras: people assume the gate is still there and never actually try the door. There are certainly other ways Epic (and any EHR) can put its thumb on the scale, but they are not so dumb as to stand in front of a federally mandated API and play bouncer at this exact moment in time. So I think they can and probably should go deeper, as this release is at best parity and at worst behind vertical-specific competition. OpenEvidence did a basic SMART launch with Sutter Health in February, allowing for more convenient evidence search by providers. They then add patient-context (the equivalent SMART on FHIR flow to what we see here) when Cedars-Sinai went enterprise-wide in May. UpToDate has four distinct applications across deeper workflows like patient engagement listed in Epic Showroom and announced a partnership with Epic to power Art at UGM Abridge and other ambient scribes have invested deeply into the deepest bidirectional clinical copilot workflow with integrations well beyond SMART on FHIR. In that light, the “Who is OpenAI primarily targeting here?” is clear. This release brings them into striking distance of OpenEvidence, but not the others quite yet. They are the only one of the three you can reach without building something truly Epic-specific. When will they go further? Competition is a great motivator to overcome the horizontal demons and start building things that can’t be reused: not across industries, not across EHRs, maybe not past the customer you built them for. That’s the price of actually verticalizing. The question is if and when OpenAI will be willing to pay it. Month in Review Here is the monthly review. As a reminder, this is a regular round-up of the month’s posts and other content to surface things you may have missed across regulation, litigation, interoperability, and beyond. AI assistance is used in these bullet summaries so I can focus on articles. Articles Published: None this month Video Content: The Information Exchange: Standards-based Thruple Edition (Aug 14): Back to school for us too, with Brad reporting in from the CMS Health Tech Ecosystem’s one year anniversary in DC. We get into the January CMS-0057 deadline, the fall rulemaking reading list, and why enrollment still keeps most apps off FHIR. The Information Exchange: Epic Dúnadan Edition (Aug 25): A UGM roundup with Ryan Brickner joining for the first time to check our takes against what the building actually thinks. Rangers, Ergo sitting on top of EHI, and a down-market lineup that needs some cuts. Regulatory: Stacked Deck, Bad Hand (Aug 05): ONC’s website refresh took the entire HIT Policy Committee record with it, so I rebuilt the archive and went looking for the regulatory capture story everyone assumes is buried in there. Stacking the deck and winning the hand turn out to be very different things. The Sixth Generation of Patient Access (Aug 19): A quick catalog of the five generations of patient access we’ve layered on since HIPAA, and the two candidates now competing to be the sixth. One is planned. The other is the market routing around the plan entirely. Court cases: Three Cases Walk Into a Docket (Aug 06): Two surprise settlements cleared the board in a single week, and then Judge Maddox dropped ninety-four pages on Vyne v. Henry Schein. The sleeper is a DMCA holding that makes direct-to-database a considerably riskier business model. Epic v. Health Gorilla: Into the MDL (Aug 10): Nine class actions are headed to Miami, and the Panel signaled it wants to bring the case that spawned them along too. That would leave Epic arguing the requests were obviously fraudulent in one courtroom and unknowable in the other. Amazon v. Perplexity: Agents Are Legalized! (Aug 11): The Ninth Circuit vacated the injunction against Comet, holding that the user is the one accessing the servers rather than the company that built the agent. A real win for agentic access, and a much narrower one than the headline suggests. Veeva v. Epic: Come At Me, Bro (Aug 26): Epic’s response brief wants the dismissal affirmed and, unusually, wants the opinion published as precedent. Buried in it is Epic’s own description of what its non-competes actually prohibit, which current and former employees should read closely. EHRs: The Contract Epic Would Never Sign Today (Aug 04): A 1999 SEC exhibit catches Epic licensing nearly its entire product line, Tapestry included, to the company that became TriZetto. The marketing services menu attached to it is the part that will make you blink. Forecast from Verona (Aug 07): The Epic Almanac makes one argument six different ways: the AI is only as good as the networks behind it. Emmie headlines, Art’s context stack is the most ambitious part, and Penny finally gets an autonomous coding date on the calendar. Works With Epic MyChart (Aug 17): Epic’s first new Showroom category since the death of Workshop certifies hardware instead of software, badge on the box and all. Made for iPhone, but for blood pressure cuffs, and rough news for anyone selling the RPM stack sitting in between. UGM Hot Takes 2026 (Aug 20): Everyone else covered the AI announcements, so I went after Savvy deleting the payment gateway, Rangers as Boost with the timer removed, and a down-market lineup with too many entries. Plus the Health Grid tidbits I cannot help myself on. MyChart Central Grows Up (Aug 24): Device data and Emmie turn Epic’s identity hub into a full consumer platform, which is both a logical answer to ChatGPT and a bit of a mistake. It also happens to be the best scraping target Epic has ever shipped. Industry Analysis: The Wrong Yardstick (Aug 12): Vertical software keeps getting judged against Superhuman and Notion, which is the wrong bar entirely. Your user is comparing your product to a whiteboard and forty phone calls before lunch. Primitives vs. Abstractions (Aug 27): Developers want building blocks, systems of record prefer to hand out business logic, and both sides have a real case. There’s no test from the outside that separates the engineering reason from the competitive one, which is why this keeps ending up in court. Cross-industry Comparisons: The Two Kinds of Platform Power (Aug 18): Attention power and record power are different problems that keep getting handed the same regulatory toolkit. Congress’s latest swing at Big Tech shows both what’s possible and where it falls apart. The Dogs of (Platform) War (Aug 21): A CourtListener alert turned up a property management fight with healthcare’s exact shape and none of the Cures Act. Shell prospects, ghost accounts, a notetaker bot that came back to haunt someone, and a lawyer arguing both sides of the same theory in two states. Fractals All the Way Down (Aug 31): Yardi dominates property management right up until you zoom into one segment, where AppFolio owns it outright and Yardi doesn’t appear at all. Where you draw the line around a B2B software market is about to decide an awful lot of cases. Other News: If Judy Had the Courage (Aug 13): A short eulogy for the era when software was allowed to look insane: WinAMP, bold colors, and everything the grey chatbot era has taken from us. External Media: Portland Monthly Health Tech Meetup: Erin O’Brien channeled my own feelings - maybe it’s just because it’s August and beautiful, but the monthly edition of the PDX Health community meetup was a ripper. Make sure to reach out if interested to join for the next one. STAT’s Coverage of Epic This Month: Brittany Trang of STAT did a fantastic job of breaking the FTC investigation that’s been lurking, as well as UGM related coverage, so I had to give her her wish of a meme. Fall Conferences: I’m pumped to be kicking off my fall conference season in NYC at Nabla Accelerate next month, which Chrissy provided the link to apply for. Here’s the rest of my schedule in case you want to meet up: Commonwell (Redwood Shores, CA): Oct 13-14 Open@Epic (Madison, WI): Oct 21-22 eHealthExchange (Austin, TX): Oct 27 Sequoia Project (Austin, TX): Oct 28-29 HLTH (Vegas): Nov 15-18 RSNA (Chicago): Nov 29-Dec 3 Posts I Liked: HTI-6 Should Unbundle API Certification: Josh Mandel makes the case that HTI-6 should split (g)(10) into separate authorization and data certifications, so a PACS or a genomics platform can certify only the role it actually performs. Imaging is the urgent example, but the structure solves a much bigger problem. On implementing ePrior Auth with Epic: Scott Rossignol’s field notes from a live ePrior Auth build on Epic, including the two app registrations nobody warns you about and the CPT mapping problem waiting at the end. CMS-0057 implementations are going to be such a beast. Healthcare point solutions are starting to look a lot like streaming services: Spencer Dorn runs the cable-to-streaming arc against health IT and lands squarely on the bundling half of the cycle. Bundling can be good! It can also be bad! Life is nuanced. Health API Guy is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Subscribe
Beth Stelling reflects on her Midwest roots
The standup comedian will visit Indy on Sept. 4 as part of Let’s Fest 2026.
August research roundup: 7 cool science stories we almost missed
Also: A surprising connection between whale calls and special relativity, tiny sound-powered drones, and more.
Samsung’s Galaxy Z Fold 8 Ultra hits its lowest price since launch
Score the launch promotion just a month after release.
Keenova Marks the 2nd Annual National Hand Health Month with New Dupuytren's Contracture Mixed Reality Experience and Awareness Initiatives
/PRNewswire/ -- Keenova Therapeutics plc today announced plans for the 2nd Annual National Hand Health Month (HHM), a nationwide U.S. observance held each...
‘Most’ of Star Wars Zero Company studio Bit Reactor was furloughed ahead of launch
Last week was meant to be a moment of triumph for Bit Reactor, the Maryland-based game studio founded in 2021 with ambitions to create a great new tactical combat game. On Thursday, August 27, Bit Reactor’s debut title, Star Wars Zero Company, released to stellar reviews. And, from the Gamescom show in Cologne, Germany, studio co-founder Greg Foertsch was giving interviews discussing what the studio’s next game may be. But for many developers on the game, launch has been bittersweet. Fans love it. Critics prefer it to most recent Star Wars games. Zero Company, which is out for PS5, Xbox Series consoles and PC, is the top-selling game on Steam. Much of the team that made it, however, is currently going without pay. They were furloughed, just weeks ahead of the game’s launch. A rep for Bit Reactor confirmed to Game File today that the studio had furloughed many of its workers prior to the game’s release. They said it was a difficult decision and one that had been made before it was clear how launch would go. The rep emphasized that the call to do this was Bit Reactor’s alone (meaning not from publisher EA nor Star Wars license holder Disney). While the rep declined to comment on the scale of the furloughs, a previously unreported lawsuit brought by studio co-founder Alison Kelly in 2024 noted in a filing from August 12 of this year that Bit Reactor “has furloughed most of its employees and terminated contractors…” One source told Game File the furloughs impacted 80% of the team; another referred to there only being a skeleton crew left on Bit Reactor’s active payroll, ready to address any of Zero Company’s post-launch bugs. The issue is that Bit Reactor, a studio formed in 2021, had run out of most of its money just ahead of the launch of its first game. Over the weekend, Zachariah Scott, a senior technical artist who worked at Bit Reactor from early 2023 until an acrimonious exit this past May, said on LinkedIn that the studio was “concealing the fact that the team was Furloughed weeks ago.” Reached by phone today, Scott told Game File that he spoke to nearly a dozen Bit Reactor workers over the weekend. “Everybody has essentially the same story, which is, ‘Yeah, I got furloughed three weeks ago.” The Bit Reactor rep told Game File that the studio hoped to bring furloughed workers back, suggesting that a successful launch of the game could be impactful. Scott told Game File that workers he spoke to were less confident that even if there were returns, that all who were furloughed would get their old jobs again. A heated dispute Bit Reactor’s mid-2026 was almost even more tumultuous. The lawsuit by co-founder Alison Kelly that first revealed the furloughs was initially slated to go to trial in June. The suit is a she-said/he-said about whether Kelly, until 2024 the chief operating officer of Bit Reactor, was a co-owner of the studio or whether it was solely owned by Greg Foertsch. In July 2024, Kelly sued, saying she was pushed out by Foertsch. She first sued in federal court and later refiled in Maryland’s Baltimore County, alleging breach of contract and that Foertsch had unjustly enriched himself. Kelly cited damages of over $20 million, on the basis of Bit Reactor allegedly being worth more than double that. Foertsch’s side has said Kelly was never a co-owner and has countered with claims about her job performance (which she has denied). The June trial was postponed until early 2027, as both sides have been deposing witnesses and filing more claims and denials along the way. Amid all of that, filings in the lawsuit reviewed by Game File paint a picture about Bit Reactor’s origins, early aspirations around tactics games, the team’s breakthrough in drawing the attention of Electronic Arts with the help of a pitch tied to one of EA’s non-Star Wars franchises, and early fractures among its co-founders. The real story about the company behind Zero Company
Wisconsin elections officials expect Milwaukee audit logs by Friday
The Wisconsin Elections Commission ended the fact-finding part of its investigation into duplicate absentee ballots in the City of Green Bay, while pressing Milwaukee to release audit logs from the August primary by Friday.
Roundup: Here's What The Critics Are Saying About The Blood Of Dawnwalker
It's reviewing very well!
📸 This week’s kit news 👕
Official announcements, leaks and great finds: OneFootball brings you a full roundup of this week’s kit news.Chelsea finally unveil their shirt sponsorAfter three years without a permanent sponsor o...
Midday transfer round-up 💰
With two days to go before the summer transfer window closes in the major leagues, several major moves are in the works or close to being finalized. Here’s a roundup of the first official announceme...
GTA 6's gameplay reveal pulled in 3.97 million peak viewers, overwhelming Twitch and Netflix in the process
GTA 6's first gameplay reveal drew more than 3.97 million peak viewers across platforms, according to new data from Streams Charts.
Engadget review recap: Google's Pixel 11 series and more
A roundup of recent reviews from Engadget.
Business roundup: New stores and restaurants land in Columbia
Four businesses have plans to open new locations in Downtown Columbia.
Business Roundup: New stores and restaurants arrive in downtown Columbia
Three new dining options and one decor store are planning to open soon in downtown Columbia.
Politics Unplugged Podcast: Headline roundup with Jim Small
Arizona Mirror editor Jim Small joins us to talk about new poll numbers, and shenanigans with candidates running under the Green Party name. Then Dennis and Colin talk about the weird political attacks on the WNBA.
Politics Unplugged Podcast: Headline roundup with Jim Small
Arizona Mirror editor Jim Small joins us to talk about new poll numbers, and shenanigans with candidates running under the Green Party name. Then Dennis and Colin talk about the weird political attacks on the WNBA.
This Week in Science: Ocean 'Backrooms', Plastic Cookies, And More!
Our weekly science news roundup.
Amazon knocks $150 off Pixel 11 phones, with up to $200 in gift cards
We also spotted discounts on the Scuf Valor Pro, a 100W battery pack, and the lowest price yet for Doom: The Dark Ages.
Market After Dark returns to downtown Cedar Rapids
Also in this roundup of Corridor entertainment news: A Sudanese native in Iowa City will give a free Oud performance this weekend, and CSPS in Cedar Rapids is hosting a film screening for “Faces of Unity.”
Alexander Dupuy’s Approach to Materials Science: Processing Possibilities
UConn materials scientist Alexander Dupuy is exploring how new approaches to materials processing could unlock advances in technologies ranging from solid-s ...
MBA Roundup: Harvard Business School Uses AI Faculty Avatars To Teach Entrepreneurship Bootcamp
Harvard Business School introduces AI clones of faculty members to help teach students in its HBS Foundry course.
Sports: High school football roundup Aug. 24
Alamosa High School’s Evan Anderson did a little bit of everything in the Moose’s impressive 20-8 opening-season win over Buena Vista Friday in Alamosa.
Mozambique strengthens regulation of medicines and imported vaccines, boosting health protection
Mozambique has reached a major milestone in strengthening the regulation of medicines and imported vaccines, with its national regulatory authority recognized by the World Health Organization (WHO) as having a stable, well-functioning and integrated regulatory system.The Autoridade Nacional Reguladora de Medicamentos de Moçambique (ANARME) has achieved Maturity Level 3 (ML3) for the regulation of medicines and imported vaccines under WHO’s global classification of national regulatory authorities.Mozambique becomes the 10th country in Africa to reach ML3, joining Egypt, Ethiopia, Ghana, Nigeria, Rwanda, Senegal, South Africa, Tanzania and Zimbabwe and marking further momentum in strengthening regulatory systems across the region.For people in Mozambique, stronger regulation means greater assurance that medicines and vaccines are appropriately evaluated for quality, safety and efficacy and monitored throughout their lifecycle. It also strengthens the country’s ability to identify and respond to safety concerns and substandard or falsified products, while supporting timely access to quality-assured health products.“Mozambique’s achievement is the result of sustained investment in regulatory capacity that will deliver crucial benefits for public health,” said Dr Sylvie Briand, WHO Chief Scientist and Assistant Director-General a.i. for Health Systems, Access and Data. “Strong regulatory systems protect people, build confidence in health products and help countries respond more effectively to evolving public health needs and challenges. Mozambique’s progress also contributes to advancing regulatory capacity across Africa and promoting more equitable access to safe and quality-assured medicines and vaccines.”Building a stronger regulatory systemMozambique’s achievement follows years of sustained efforts to build the institutions and capabilities needed for effective regulation.WHO worked closely with ANARME throughout this process, assessing the national regulatory system and supporting the authority in addressing identified gaps and strengthening priority areas.WHO evaluates national regulatory systems using its Global Benchmarking Tool (GBT), which assesses the regulatory functions required to ensure the quality, safety and efficacy of medical products. These include registration and marketing authorization, licensing, market surveillance and control, pharmacovigilance, regulatory inspection, laboratory testing and oversight of clinical trials, as applicable. WHO’s maturity levels range from 1 to 4. Reaching ML3 confirms a stable, well-functioning and integrated regulatory system, while ML4 represents an advanced system focused on continuous improvement.Benefits for Mozambique and the African continentAn ML3 regulatory system can support more timely and predictable regulatory decisions, reinforce safety monitoring and help ensure that health products entering and remaining on the market meet appropriate standards.It also creates greater opportunities for regulatory cooperation and reliance – approaches that help authorities make use of the work and decisions of trusted regulators, reduce unnecessary duplication and allocate limited resources more efficiently, while maintaining rigorous standards for quality, safety and efficacy.As the first Portuguese-speaking country in Africa to reach ML3, Mozambique’s experience can also contribute to strengthening regulatory systems and fostering greater cooperation, knowledge sharing and reliance among Portuguese-speaking countries and across the African continent. Its achievement further reinforces a more connected African regulatory ecosystem, providing a solid foundation on which the newly established African Medicines Agency can build to advance regulatory convergence and cooperation across the region.Strengthening confidence in regulatory recognitionMozambique’s achievement comes as WHO strengthens the process through which the performance of national regulatory systems is recognized.The newly established Technical Advisory Group on Regulatory Systems Strengthening (TAG-RSS) brings together independent international experts to advise WHO on whether recommendations concerning regulatory authorities reaching ML3 and ML4 and WHO-Listed Authorities, are supported by the findings of WHO evaluation processes. Its recommendations provide an additional level of independent assurance, strengthening the impartiality, transparency and credibility of WHO’s recognition process.Mozambique is among the first countries to achieve ML3 following consideration and recommendation by the TAG-RSS. As part of the same TAG-RSS process, South Africa was recommended to retain its ML3 status for the regulation of vaccines manufactured, imported or distributed in the country, following an additional WHO assessment. This extends the recognition first granted in 2022 and underscores the sustained performance of the South African Health Products Regulatory Authority (SAHPRA).The two recognitions highlight continued progress in strengthening regulatory systems across Africa, as well as the importance of continued performance, improvement and assessment in sustaining regulatory maturity.WHO will continue working with ANARME and SAHPRA to sustain these gains and support continuous improvement as science, technologies and public health needs evolve.
The New Shokz OpenFit Air 2 Earbuds Are Nearly 20 Percent Lighter Than The Previous Generation
They feature an open-ear design that reduces pressure and heat buildup.
Waco roadwork roundup: Twin Bridges traffic shift begins, big changes proposed for I-35 and Business 77
From the Highway 6 Twin Bridges to Interstate 35 and future plans along Business 77, Waco and road construction are going hand in hand this season. State transportation officials are moving forward with major traffic switches and lane closures, while simultaneously planning long-term re-designs to local roadways.
Bipartisan Energy Politics | Reading and Podcast Picks
Reading and Podcast Picks is a collection of what we’ve been reading and listening to over the last week or so about energy topics. In addition to these R&P Picks, paid subscribers receive access to the full archives, Grid Roundups, and select episodes of the Energy Capital Podcast. Please subscribe today. Texans, legislators debate transmission lines at hearing | Texas Tribune “Republican legislators, Democratic statewide candidates, landowners from rural Texas and environmentalists” alike joined together Wednesday to protest the buildout of 765-kV lines across the state. At the protest and nine-hour hearing that followed, lawmakers heard a variety of recommendations, including from local officials arguing for more local control of data center proposals and more time to reform the process behind approving transmission lines across Texas. Though discussed in separate hearings, landowners and protesters said the issues are connected… Regulators have already been working through a new way to decide how much of the cost of building new transmission lines needs to be paid for by individuals and how much needs to be paid for by companies such as data centers. Experts said they believe the new system will lower the burden on residential consumers relative to the industrial groups. Data-Center Backlash Leads to New Land Rush in Texas Oil Patch | The Wall Street Journal While the data center protests rage, investors converge on the Permian Basin to build data centers powered by cheap natural gas. “A lot of places you see all over the country they’re worried about water, they’re worried about power, they’re worried about transmission, and the Permian has all of those things in spades,” said EagleRock Chief Executive Greg Pipkin Jr. Dallas-Fort Worth Dethrones Virginia as the World’s Top Data Center Market | Dallas Innovates Two reports show growth in North Texas data centers despite political concerns about the industry. Boasting five highly ranked data center markets, Texas is experiencing an explosion of data center activity. Long anchored by the DFW market, “the state is growing at a pace that could soon bring total installed capacity in line with — and potentially beyond — that of Virginia,” the Cushman & Wakefield report said. A new report from commercial real estate services provider JLL takes a slightly different view, anointing Texas the top data center market in North America. Texas eclipsed longtime frontrunner Virginia based on the level of existing and under-construction data center inventory in the state as measured by gigawatt capacity. A gigawatt equals 1 billion watts.
JumpStart gets new Stark director and other news
In the latest "Business Roundup," we share news about JumpStart, Airgas, Timken, Aultman, Mercy and Liberty HealthShare.
'The greatest unknown was how much energy would be released by the weapon': How scientists prepared for the Trinity nuclear test
In this excerpt from "Trinity: An Illustrated History of the World’s First Atomic Test," author Emily Seyl looks at the buildup to the 1945 test that changed history. She explores the huge effort to design experiments that would ultimately establish whether the gargantuan explosion in the middle of the desert was a success.
Roundup: ChatGPT / GM engine failures / US business activity surges
Convenience meets risk: OpenAI has added a ChatGPT feature that can search, analyze, draft and send messages through Apple’s Messages app on Macs, making it easier to manage conversations and automate tasks. While convenient for personal and business use, the integration requires expanded access to contacts and computer data, raising concerns about sensitive information being […]
Kennedy Promised 'Radical Transparency' and 'Gold-Standard Science.' Trump's Vaccine Order Promotes Neither.
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
Morning 4: Here are the 80 businesses you voted best in Metro Detroit
Morning 4 is a quick roundup of stories we think you should know about to start your day.
Your Weekly Michigan Political Brief
The League of Conservation Voters Action Fund has endorsed Democrat Abdul El-Sayed for the U.S. Senate. VoteVets announced its endorsement of Callie Barr, Democratic candidate for Michigan’s 1st Congressional District. Ben Ambrose, Democratic candidate for Michigan’s 2nd Congressional District, has been endorsed by United Food and Commercial Workers (UFCW) Local 951. Joanna Whaley, Democratic candidate […]
This Week in Science: Highest Radiation Occupation, a Shooting Star, And More!
Our weekly science news roundup.
Roundup: ExxonMobil / SBA workforce initiative / New HoganTaylor CEO
Anti-trust charges tossed: A Texas Business Court judge dismissed Clean Hydrogen Works’ antitrust claims against ExxonMobil’s Denbury subsidiary, ruling Texas courts cannot address alleged antitrust injuries occurring outside the state. Clean Hydrogen Works alleges Exxon used its control of Denbury’s 620-mile carbon dioxide pipeline network to block a planned $7.5 billion clean-fuels project in Louisiana, […]
Recruiting Roundup: 5-star DL feeling the love from Wolverines
The new Michigan Football coaches are prioritizing a 5-star DL that was offered by the previous staff. That and more in today’s Recruiting Roundup:
Health Care Roundup: Market Talk
Find insight on Moderna, Novonesis, Merck KGaA and more in the latest Market Talks covering the health care sector.
Sandra Bullock breaks silence on ‘traumatic’ death of partner Bryan Randall
Sandra Bullock says she grieved her late partner Bryan Randall ‘four years before he passed’ as he battled ALS until his death in 2023.
Roundup: Partnership CEO search / Broadband expansion / Tariff negotiations
Time frame: The Greater Baton Rouge Economic Partnership tells Daily Report it expects to have a new CEO in place in three to four months. The organization launched its national search for a new CEO on Aug. 4. While internal milestones won’t be shared, the Partnership says it remains committed to moving thoughtfully and steadily […]
The Latest Resources from AVAC: Advancing Science, Expanding Access
Scientific breakthroughs accelerate HIV prevention—but only when they are matched with bold advocacy, sustained investment and equitable access. This month’s roundup highlights key prevention news, developments and takeaways from AVAC and explores what’s needed and what’s next to ensure the latest innovations move beyond headlines and into the hands of the communities that need them […]
Biz Beat Roundup: Stafford considering business tax
Also inside: Local Habitat chapter building six homes in Fredericksburg, downtown restaurant celebrates milestone anniversary, European-style restaurant opens in Spotsylvania
The week in politics (Aug. 19, 2026)
On Wednesday's show: We discuss the latest developments in politics in our weekly roundup. And we contemplate what Houston might've been like if Texas had been allowed to split into five separate states.
Paying More to Stay Cool, Super El Niño, Solar Politics
Energy affordability and data center opposition are among the most potent political messages in 2026. The Drain is a roundup of climate news.
Roundup: Here's What The Critics Are Saying About The Sinking City 2
Does it sink or swim?
Health Care Roundup: Market Talk
Find insight on Cochlear, Sandoz and more in the latest Market Talks covering the health care sector.
Roundup: Louisiana International Terminal / Ethane demand / Robot rush
Gateway to growth: The U.S. Army Corps of Engineers has granted the federal permit for the Louisiana International Terminal, clearing the way for construction of a major new container port on the Lower Mississippi River. Backed by Port NOLA, Terminal Investment Limited and Ports America, LIT is designed to handle the world’s largest container ships […]
Roundup: The First Reviews Have Arrived For Mortal Shell 2
A significant improvement over the original?
Nature-inspired coating repels both water and ice
A PFAS-free coating could help protect aircraft, wind turbines, and power lines from hazardous ice buildup.
Nintendo Switch eShop latest sales: lowest prices ever for Front Mission remakes, New Super Lucky's Tale, more
A bunch of new sales are up and running on the North American Nintendo Switch eShop. These include the lowest prices ever for the Front Mission remakes, New Super Lucky’s Tale, and more. Here’s the full roundup: – A Memoir Blue – $2.79 (was $7.99) – AEW: Fight Forever – $15.99 (was $39.99) – Arcade Archives Bosconian – $5.59 (was...
A little-known protein may be fueling Alzheimer’s — and scientists found a way to block it
An experimental Alzheimer’s compound prevented damaging protein clumps from forming in the brains of mice, helping nerve cells survive longer and reducing amyloid buildup. The treatment also appeared to improve heart health and slow some signs of aging, raising hopes for an entirely new way to combat dementia.
Belleville business news includes cafés, burritos and big real estate deals
A roundup of the week’s business stories.
This Week in Science: AI Agents Come to an Agreement, Gemstones on Mars, And More!
Our weekly science news roundup.
This Week in Science: AI Agents Come to an Agreement, Gemstones on Mars, And More!
Our weekly science news roundup.
Your Weekly Michigan Political Brief
Abdul El-Sayed announced that he had been endorsed by the Michigan Democratic Party Black Caucus in his run for U.S. Senate, alongside the entire Michigan Democratic slate for the 2026 midterm elections. El-Sayed was also endorsed by the Planned Parenthood Action Fund. The Michigan Education Association has recommended Michigan Secretary of State Jocelyn Benson’s Democratic candidacy for […]
Orthopedic services expand in Duplin County as ECU Health strengthens Kenansville practice
ECU Health says they are expanding orthopedic services in Duplin County with the addition of Dr. Robert Friedman at ECU Health Orthopedics – Kenansville.Friedma
ROUNDUP: Katie Hobbs Meets With Kingman Small Business Owners and Rallies Supporters in Bullhead City
KINGMAN – Last week, Gov. Katie Hobbs stopped by Mudd on 66 in Kingman, Arizona to tour the establishment and hear directly from the owners about how rising costs driven by Washington, D.C. policies have affected their day-to-day operations and their ability to thrive. She later joined local leaders, organizers, and volunteers to officially open the […]
Preseason Power Rankings Roundup: Can Cowboys crack Top 10?
Dallas is looking to turn their recent fortunes around, and may be turning enough heads for onlookers to take notice.
The week in politics (Aug. 12, 2026)
On Wednesday's show: We discuss the latest developments in politics in our weekly roundup. And we reflect on the classic film "Casablanca" ahead of a screening at the River Oaks Theatre.
Sacramento news roundup: climber death, hotel tax fraud, health bill, worker benefits
Here is a quick recap of the top stories from The Sacramento Bee on Tuesday, August 11, 2026.
Michigan Football trending up with ELITE wide receiver recruit
Michigan Football is trending up for an elite WR that is teammates with two recruits committed to the Wolverines. That and more in today’s Recruiting Roundup:
The Elder Scrolls III: Morrowind Review Roundup
Critics found a lot to pull apart in this anticipated sequel to Daggerfall, but found Morrowind was more than the sum of its parts
Super Mario Sunshine Review Roundup
Critics adore Mario’s latest jump in 3D, even if it’s not as groundbreaking as they’d have hoped
Roundup: AI construction jobs / Jalapeño recall / US battery production
BlackRock partnership: BlackRock and its AI Infrastructure Partnership are partnering with North America’s Building Trades Unions to connect upcoming data center and energy projects with skilled construction workers. The agreement aims to address labor shortages while promoting fair wages, job protections and training, amid concerns about AI’s impact on employment and communities affected by large […]
Eleven Arkansas students place in 2026 Soybean Science Challenge
Eleven Arkansas students earned honors in the 2026 Soybean Science Challenge for innovative agricultural research and sustainable projects.
Yankees Social Media Spotlight: Welcome to the Concrete Jungle
A trio of new Yankees take the lead in this week’s social media roundup.
This Week in Science: Mosquito Magnets, Bonus Benefits of GLP-1s, And More
Our weekly science news roundup.
Food Tank’s Weekly News Roundup: U.S. Restores Health Aid, Companies Block Action on UPFs, New Tool Boosts Water Security
This week, the U.S. restores some health aid, corporations slow action on public health, and a tool boosts water security for women farmers.
Shane Gillis’ mom skipped out on his record-breaking standup show for vacation
Controversial comedian Shane Gillis broke two Guinness World Records for a recent standup show at Philadelphia’s Lincoln Financial Field.
iPhone 18 Pro rumor roundup: 2nm A20 chip, C2 modem, under-display Face ID
Apple's iPhone 18 Pro is right around the corner, and the rumor mill started earlier than normal. Here's what you need to know.
Roundup: CC’s drive-thru / Meta ordered to pay / ‘Basic business class’
Coffee in a hurry: CC’s Coffee House is opening its first drive-thru-only location at 319 W. Highway 30 in Gonzales on Aug. 8, offering a faster way for customers to enjoy coffee, breakfast and other menu favorites. The new store, located just off Interstate 10, will have a grand opening celebration Aug. 10-13 featuring daily […]